BACKGROUND/OBJECTIVES: The objective of this study was to assess vitamin D status and possible consequences of low plasma 25-hydroxyvitamin D (25OHD) levels in a population of healthy mothers and their infants. SUBJECTS/METHODS: A total of 107 women aged 24-41 years gave birth to 108 infants. They were followed up three times during 9 months. RESULTS: Cord blood 25OHD level (43.3 ± 20.4 nmol/l) on average was 62 ± 16% of maternal levels (73.3 ± 30.7 nmol/l), measured 1-2 weeks postpartum. Cord blood 25OHD correlated positively with maternal 25OHD levels (r ¼ 0.83, Po0.001). At birth, 23% of mothers and 61% of infants had 25OHD o50 nmol/l. Vitamin D deficiency (25OHDo25 nmol/l) was present in 66% of the children born by mothers with 25OHD levels below 50 nmol/l (Po0.01), whereas only one child was born with deficiency among mothers with 25OHD 450 nmol/l. During follow-up, most of the children (485%) had 25OHD levels 450 nmol/l, which most likely was attributable to the use of supplements, as more than 95% of the children were given daily vitamin D supplements of 10 mg of vitamin D. Cord blood parathyroid hormone levels were very low (median 0.21; interquartile range 0.11-0.33 pmol/l), with increasing levels (Po0.01) reaching 3.08 (2.67-3.92 pmol/l) at the last visit. Vitamin D levels were not associated with anthropometric indices of the newborn infant or their growth during follow-up. CONCLUSIONS: Vitamin D deficiency is widespread in newborn. Maternal 25OHD levels above 50 nmol/l are needed to prevent vitamin D deficiency among newborn.
INTRODUCTION
Vitamin D deficiency is widespread. 1, 2 Pregnant and lactating women and their newborn infants are at a high risk of vitamin D deficiency. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Vitamin D is involved in skeletal homeostasis during pregnancy. 13, 14 Severe vitamin D deficiency with profound hypocalcemia may lead to seizures in neonates, and has also been associated with low birth weight, prenatal death, preeclampsia and an increased risk of primary cesarean section. [15] [16] [17] [18] [19] In utero, the fetus is entirely dependent on vitamin D from their mothers. 8 Following birth, vitamin D status depends on ethnicity, food, vitamin D supplementation and season. 20 The vitamin D content of breast milk is modest and has been reported to be insufficient to cover the child's vitamin D need. 20, 21 Accordingly, pregnant and breastfeeding women in Scandinavia are recommended to use a daily supplement of 10 mg (400 IU) of vitamin D. 22, 23 Furthermore, it is recommended that children aged 2 weeks to 2 years receive a daily supplement of 10 mg of vitamin D. 22, 23 Whether these recommendations are adequate is still uncertain, as recent studies have suggested that the supplement should be increased to 25-100 mg per day. 5, 20, [24] [25] [26] [27] [28] In a population-based cohort study, we aimed at the following: (1) to investigate the prevalence of vitamin D deficiency and insufficiency in Caucasian infants and their mothers at birth and 4 and 9 months after birth; (2) to identify determinants of maternal and infant vitamin D status and to appraise associations between vitamin D status in the newborn children and their mothers; (3) to investigate interactions between plasma 25-hydroxyvitamin D (25OHD) and parathyroid hormone (PTH) levels; and (4) to assess the influence of plasma 25OHD and PTH levels on infant body weight and growth rates.
SUBJECTS AND METHODS
From October 2008 to October 2010, we recruited healthy Caucasian women aged 24-41 years via all midwife centers in the community of Aarhus, Denmark (latitude 561N). Midwifes handed out an invitation to participate in the study to the pregnant women at their first visit at the clinic. The invitation was also handed out when the pregnant women came to the maternity ward for a visit. Approximately 3000 brochures were handed out (Figure1).
We only included healthy pregnant Caucasian women aged 24-41 years, with a normal pregnancy, giving birth between 38 and 42 gestational weeks. Exclusion criteria were chronic diseases or abuse of alcohol or drugs. A total of 157 women accepted the invitation, among whom 50 were excluded for various reasons (Figure 1 ). We sampled cord blood at baseline and blood samples from the children at 4 months (first follow-up) and 9 months (second follow-up) after birth. Maternal blood was collected at 2 weeks after birth (baseline) and at the first and second follow-up visit. At all three visits we also collected information on breastfeeding status, use of vitamin D supplements among children and their mothers, use of calcium supplements and dietary calcium intake.
In this context, we defined vitamin D deficiency as plasma 25OHDo25 nmol/l, insufficiency as plasma 25OHD between 25 and 50 nmol/l, sufficiency as plasma 25OHD between 50 and 75 nmol/l and a replete status as 25OHD475 nmol/l. [29] [30] [31] The study was conducted according to the Helsinki Declaration II. 
Biochemistry
At birth, cord blood was collected into EDTA tubes and stored in a refrigerator ( þ 5 1C) for a maximum of 72 h before being processed. Non-fasting blood samples from mothers and infants were collected between 0800 and 1130 hours. All blood samples were stored at À 80 1C until analyzed.
We analyzed plasma 25OHD levels by isotope dilution liquid chromatography-tandem mass spectrometry according to a method adapted from Maunsell et al. 32 and described earlier in detail. 33 The method quantifies both 25OHD 2 and 25OHD 3 . Calibrators traceable to NIST SRM 972 (ChromSystems, Gräfeling, Germany) were used. As cord blood was stored for up to 72 h before analyses, we evaluated the stability of 25OHD measurements in blood collected in either serum gel tubes or EDTA plasma tubes and stored for 3 days at either room temperature (B20 1C) or at þ 5 1C before processing. Compared with serum sample frozen immediately (gold standard), the percentage retrieval following storage at room temperature was 98.3% (95% confidence interval (CI), 91.2-105.5%) for serum and 97.7% (95% CI, 90.9-104.6%) for EDTA plasma.
Following storage at þ 5 1C, percentage retrieval was 90.3 (95% CI, 82.2-98.5%) for serum and 98.8% (95% CI, 90.7-107.1%) for EDTA plasma. Accordingly, we chose EDTA plasma for collection of cord blood samples, which was stored in a refrigerator at þ 5 1C before processing within 72 h. We measured plasma intact PTH using a secondgeneration electrochemiluminescent immunoassay on an automated instrument (Cobas 6000, Roche Diagnostics, GmbH, Mannheim, Germany). The lower limit of detection of the assay is 0.127 pmol/l, with a total imprecision (CV %) of 3.3% and 2.7% at PTH levels of 3.7 and 26.6 pmol/l, respectively. Plasma levels of ionized calcium and creatinine were measured by routine methods using ISO9000 standards.
Dietary supplements and intakes
Maternal and infant vitamin D supplements and maternal calcium supplements were assessed at each visit. Data on dietary vitamin D intakes were not available. Maternal dietary calcium intakes were assessed according to the method proposed by Hermann et a. 34 The maternal total calcium intakes were calculated as the sum of dietary calcium and calcium supplements.
Statistics
We described variables by mean ( ± s.d.) or medians (25 and 75-percentile (p25-p75)) or range (minimum-maximum) depending on distribution. 
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In a bivariate model, determinants of vitamin D status and PTH were examined. Effects of season were studied by comparing summer (May to October) and winter (November to April) values. We used Pearson's correlation coefficient for analyses. Using multiple linear regression analyses, we assessed determinants of vitamin D status and birth outcomes.
Between groups, differences over time were assessed by repeated measure of variance and by a two-sampled t-test or Wilcoxon signed rank test. As vitamin D intake from supplements was assessed at each visit, we calculated average intakes during the 9 months postpartum. All calculations were performed by SPSS (version 19.0; SPSS Inc., Chicago, IL, USA). Figure 1 shows recruitment of the 130 women included in the study. After inclusion, but before giving birth, 23 pregnant women dropped out because of personal reasons, illness or change of residence, leaving 107 pregnant women for study. The women gave birth to 108 healthy children among whom 62 (57.4%) were boys. Table 1 shows characteristics of the infants and their mothers at baseline and each of the follow-up visits. The women had a median age of 30 (range 24-41) years and a body weight of (mean ± s.d.) 69.9 ± 9.0 kg at the first visit. During follow-up, their weight decreased to 65.5±8.4 kg at the last visit. At birth, the infants had a mean weight of 3.597 ± 391 g, and had a length of 52.9 ± 2.0 cm. Their weight and length increased to 9.347 ± 957 g and 74.8 ± 2.8 cm, respectively, at the last visit.
RESULTS

Maternal vitamin D status
At the first visit, maternal 25OHD level was 73.3 ± 30.7 nmol/l, and 85 (79%) women reported the use of vitamin D supplements. On average, plasma 25OHD levels were 25 (95% CI 12-39) nmol/l lower in women not using supplements (53.1 ± 25.4 nmol/l) compared with those using supplements (78.5±29.8 nmol/l, Po0.001). During follow-up, the proportion of women using vitamin D supplements decreased with a concomitant decrease in 25OHD levels, whereas PTH levels increased (Table 1) .
At the first visit, 3% of the mothers had 25OHDo25 nmol/l, 20% had 25OHD between 25 and 50 nmol/l, whereas 33% had 25OHD between 50 and 75 nmol/l and 45% had 25OHD above 75 nmol/l. At visits 2 and 3, the corresponding percentages were 3, 19, 48, 30% and 10, 38, 39, 14%, respectively. Levels varied as a function of season, as shown in Figure 3 .
Infants' vitamin D status Mean cord blood 25OHD concentration was 43.3 ± 20.4 nmol/l, that is, 62±16% of the maternal levels with a significant positive correlation (r ¼ 0.83, Po0.001) between infant and maternal levels ( Figure 2) . From the regression line, cord blood 25OHD could be estimated from maternal plasma 25OHD according to the following equation: cord blood 25OHD (nmol/l) ¼ 0.57 Â maternal 25OHD (nmol/l) þ 3.55 (s.e. of the estimate (SEE): 11.0 nmol/l). None of the infants had plasma 25OHD levels above the level in their mothers. During follow-up, vitamin D supplements were administered to most infants (490%) and mean plasma 25OHD levels increased significantly in the infants (Table 1) . Concomitantly, the proportion of infants with low vitamin D levels decreased. At birth, 15% of the infants had plasma 25OHD levels o25 nmol/l, 46% had plasma 25OHD levels between 25 and 50 nmol/l and 20% had plasma 25OHD levels between 50 and 75 nmol/l, whereas only 7% had plasma 25OHD levels above 75 nmol/l. During follow-up, the percentages were 0, 4, 17, 73% and 1, 4, 23, 64% at visits 2 and 3; 10% and 2% of the infants had 25OHD 4125 nmol/l at visit 2 and visit 3, respectively. Levels varied as a function of season as shown in Figure 3 .
In the group of mothers with plasma 25OHD levels above 50 nmol/l, only one child was born with plasma 25OHD levels below 25 nmol/l, whereas vitamin D deficiency (25OHD o25 nmol/l) was present in 66% of the children born by mothers with plasma 25OHD levels below 50 nmol/l (Po0.01).
As shown in Table 2 , maternal plasma 25OHD level was the only significant determinant of infant plasma 25OHD levels at birth and visit 2, whereas season was of importance at visit 3. For maternal plasma 25OHD levels, intake of vitamin D from supplements, body mass index and season were of significant importance. Infants born by mothers who use vitamin D supplements had higher (P ¼ 0.03) 25OHD cord blood Plasma PTH levels in the infants and their mothers At birth, PTH levels in cord blood were very low, but increased during follow-up (Table 1) . Maternal plasma PTH levels also increased (Po0.01) during study (Table 1 ). In the mothers, plasma PTH levels did not differ between users and non-users of vitamin D supplements at any of the three visits (data not shown). However, significant, although weak, inverse correlations (r 2 values at the three visits were in the range of 10%) between maternal plasma 25OHD and plasma PTH levels were evident at all three visits. When relating the infant plasma PTH levels to plasma 25OHD using the same model, no significant correlations were seen at any of the visits.
Seasonal variation
Both maternal and infant plasma 25OHD levels showed seasonal variations ( Figure 3) . Accordingly, the prevalence of vitamin D deficiency and insufficiency varied by season (Figure 3) . Plasma PTH levels showed no consistent seasonal variation. Only at the first visit, women who had given birth at winter time had higher plasma PTH levels than women giving birth at summer time.
Associations between vitamin D status, plasma PTH levels and infants' growth At birth, infants' weight was determined by their sex and length of pregnancy (Table 3) . Stratification by sex did not change these results; that is, except for the length of pregnancy, none of the 
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other included variables were significant predictors. In addition, sex was a significant predictor of changes in weight during follow-up. Similarly, sex and duration of pregnancy were significant predictors of length of the newborn child (data not shown). Plasma 25OHD and plasma PTH levels did not affect the weight or length of the newborn child or the changes in weight or length during the first 9 months of life.
However, repeated measures analysis of variance of plasma PTH in the infants at birth, and at 4 and 9 months of age, as determined by sex, season, mother's vitamin D intake, vitamin D supplement to infant, mother's plasma PTH, infant weight and maternal plasma 25OHD, showed that changes in plasma PTH over time in the infant correlated positively with infant weight (Po0.05). None of the other variables attained statistical significance.
DISCUSSION
In a cohort of women and their newborn infants, we found a significant correlation between maternal plasma 25OHD concentration and cord blood levels of 25OHD at birth, which is in accordance with previous studies. 10, 28, [35] [36] [37] Our study showed that maternal plasma 25OHD levels above 50 nmol/l are needed to assure that almost no children are born with very low plasma 25OHD (o25 nmol/l) levels. A low percentage of the mothers were vitamin D deficient (3%) shortly after birth, whereas a relatively high proportion of the mothers were in the range of insufficiency (20%), despite the fact that most of the women used vitamin D supplements. However, among the children, the percentages with low vitamin D levels were much higher, with 15% being categorized as deficient and 46% as insufficient at birth. The observed level in the studied infants is In the model, female and male sex were coded as 1 and 2, respectively. *Po0.05, **Po0.01. Numbers are regression coefficients (b) and standard error of the mean (s.e.m.) with squared correlation coefficient (r 2 ).
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quite low, as the American Academy of Pediatrics, the Pediatric Endocrine Society and the 2011 IOM report support a plasma 25OHD concentration of at least 50 nmol/l as likely to be consistent with the physiological needs of infants' and children. [38] [39] [40] However, in our study, infant plasma 25OHD levels increased to a reasonable level during follow-up, suggesting an appropriate effect of the vitamin D supplementation given to the majority of the infants.
The main determinant of cord blood levels of 25OHD was maternal plasma 25OHD concentrations at the time of birth. The correlation between maternal and infant plasma 25OHD was maintained even 4 months after birth. These extended correlations with maternal birth values may signal an effect of maternal lifestyle. This raises questions on whether the current recommendations on vitamin D supplements to pregnant women should be revised, as infants born by mothers who use supplements had significantly higher 25OHD cord blood levels than infants born by mothers who do not use vitamin D supplements.
In our study, cord blood PTH levels at birth were very low in infants. This is in line with the study of Bowyer et al. 41 Seki et al.
42 found a significantly lower PTH level in cord blood compared with maternal blood at birth, and this was in accordance with the results of Allgrove et al. 43 who found low PTH levels in cord blood. They supported the contention that PTH secretion is suppressed by hypercalcemia in late fetal life, and thus Seki et al. 42 suggest that stimulation of the placental calcium pump by PTHrP may be operative in humans, leading to low cord blood PTH at birth. In addition, one has to be aware that in the fetus PTH and calcium levels is probably of minor importance to circulating levels of 1,25(OH)2D, as 1,25(OH)2D levels primarily depend on the maternal supply of 25OHD. 44, 45 During follow-up, the main determinant of plasma PTH was infant body weight, which probably reflects an increased need for calcium with skeletal growth as the infants' own parathyroid glands are taking over following birth. [46] [47] [48] [49] However, our data do not exclude that plasma PTH per se may exert an effect on growth and body weight. Importantly, because of the design of our study, it does not allow for conclusions on cause-effect relationships.
Our findings of a correlation between plasma PTH levels and weight is similar to the findings in adults, that is, that an increased body weight (which in adults have been shown to be mainly due to an increased fat mass) is positively associated with PTH levels. 50, 51 However, in contrast to previous studies in adults, 52, 53 as well as in contrast to the findings in our studied women, our analyses did not show an inverse correlation between plasma 25OHD and PTH levels in infants. We do not believe that this necessary suggest an altered relationship between plasma 25OHD and PTH levels in newborns. Rather, it may be explained by the fact that our studied infants had relatively high plasma 25OHD levels (due to a high frequency of use of supplements), making it difficult to show a significant statistical inverse relationship.
Strengths and limitations
The strength of our study was the high number of participants, the low dropout rates and the extended biochemistry and lifestyle variables. The limitations were that there was no a pregnant/ lactating control group. Furthermore, that the study participations may be influenced by a number of factors, so-called 'healthy worker effect', that is, that mostly healthy well-educated women may have chosen to participate in our study. In addition, it has to be acknowledged that a specific reference range for 25OHD levels is not available in newborn/infants, and we do not know whether the adult reference range as applied in our study is of relevance to newborn/infants. CONCLUSION Vitamin D deficiency is widespread in newborn Danish children. Maternal vitamin D intake from supplements is a determinant of maternal plasma 25OHD levels, and maternal 25OHD status at birth is the major determinant of infant 25OHD status. The use of vitamin D supplement is thus a feasible way to improve vitamin D status in pregnant women and their newborn children, and the use of vitamin D supplements in a daily dose of 400 IU seems to be a reasonable way to ensure a replete vitamin D status in infants during their first 9 months of life.
